Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.
{iframe}https://www.axios.com/roche-buys-flatiron-health-1518725569-8c129313-42dc-448f-ac8b-1c716d49e481.html{/iframe}